sprite-preloader
Anzeige
Mehr »
Freitag, 26.05.2017 Börsentäglich über 12.000 News von 573 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen
21.04.2017 | 14:09
(3 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

BIRMINGHAM, Alabama, April 21, 2017 /PRNewswire/ --BioGX, a developer and manufacturer of molecular diagnostics CE-IVD tests has announced the establishment of European operations based in Amsterdam, Netherlands. BioGX EU operation is at the core of the company's growth strategy into the European market with a goal to place sales, supply and support resources closer to its European customers. BioGX EUwill provide direct supportto customers in Europe, the Middle East and Africa (EMEA)through regionaltechnical sales and field application resources.

BioGX_Logo

According to Shazi Iqbal, Ph.D., CEO of BioGX, "BioGX EU operations will enhance the customer experience and lower costs by eliminating the complexity and expense associated with an international supply chain. BioGX is well positioned to offer its full range of products and services to customers throughout the EMEA region."

About BioGX
BioGX manufactures molecular diagnostic CE-IVD tests and provides partner-specified formulation and manufacturing services for custom molecular reagent components. Operating in a cGMP compliant environment, BioGX has a decade of experience in applyingits proprietary platform-agnostic reagent technology across a variety of real-time PCR and Next Generation Sequencing platforms. The Sample-Ready' technology is applied withinclinical, food safety, pharma, and water quality analysis industries worldwide.For itsachievements in exporting goods and services around the world, BioGX was honoredwith the 2017 Alabama Governor's Trade Excellence Award.

Logo - https://mma.prnewswire.com/media/415789/BioGX_Logo.jpg



© 2017 PR Newswire